BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2022
View Archived Issues
Tyrosine kinase inhibitor NTRC-0652-0 shows promise for the treatment of cholangiocarcinoma
Read More
New prolyl endopeptidase inhibitors identified at Accure Therapeutics
Read More
ReViral describes new compounds for respiratory syncytial virus infections
Read More
Mcl-1 inhibitors discovered at Janssen
Read More
3M Innovative Properties divulges new Toll-like receptor 7 agonists
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Bcl-2 and/or Bcl-X inhibitors
Read More
Endothelial BCAR1 expression associated with antiangiogenic therapy resistance
Read More
Discovery of novel MBL inhibitors as promising beta-lactam antibiotics
Read More
Epigenetic-mediated immune mechanisms identified in TB
Read More
A microbiota-macrophage-iron axis regulates hematopoietic stem cell fate decisions under stress
Read More
A comprehensive catalog of functional cell types and cellular states in human brain metastases
Read More
Targeting PPARalpha-ACOT12 axis as a potential new therapeutic strategy for osteoarthritis
Read More
PLA2-IIA modulates immunity through its interaction with microbiota
Read More
CIRM grant supports Juvena's preclinical work on JUV-161 for myotonic dystrophy type 1
Read More
Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases
Read More
Anakuria's AT-20494 to be studied for ADPKD and other indications
Read More
